Mingdong Lu

1.1k total citations
41 papers, 719 citations indexed

About

Mingdong Lu is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Mingdong Lu has authored 41 papers receiving a total of 719 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 14 papers in Oncology and 11 papers in Immunology. Recurrent topics in Mingdong Lu's work include Gastric Cancer Management and Outcomes (6 papers), Cancer Immunotherapy and Biomarkers (6 papers) and MicroRNA in disease regulation (5 papers). Mingdong Lu is often cited by papers focused on Gastric Cancer Management and Outcomes (6 papers), Cancer Immunotherapy and Biomarkers (6 papers) and MicroRNA in disease regulation (5 papers). Mingdong Lu collaborates with scholars based in China, United States and Czechia. Mingdong Lu's co-authors include Weijian Sun, Pihong Li, Xian Shen, Zhiqiang Zheng, Liyi Li, Xiangwei Sun, Chenbin Chen, Sian Chen, Xiang Zhou and Xiangyang Xue and has published in prestigious journals such as ACS Applied Materials & Interfaces, Small and Biochemical Pharmacology.

In The Last Decade

Mingdong Lu

37 papers receiving 711 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mingdong Lu China 15 463 245 146 131 69 41 719
Francesco Ciccarese Italy 13 436 0.9× 260 1.1× 117 0.8× 98 0.7× 41 0.6× 17 694
Binbin Yu China 15 374 0.8× 224 0.9× 126 0.9× 95 0.7× 82 1.2× 36 585
Chunhua Ling China 17 422 0.9× 296 1.2× 111 0.8× 112 0.9× 37 0.5× 45 658
Xi Yu China 15 410 0.9× 227 0.9× 162 1.1× 101 0.8× 59 0.9× 43 747
Tianli Fan China 14 609 1.3× 391 1.6× 167 1.1× 92 0.7× 65 0.9× 29 832
Maria Rita Milone Italy 12 321 0.7× 182 0.7× 134 0.9× 119 0.9× 60 0.9× 16 556
Vijesh Kumar Yadav Taiwan 18 502 1.1× 310 1.3× 173 1.2× 147 1.1× 62 0.9× 41 814
Xiqiang Cai China 11 385 0.8× 225 0.9× 154 1.1× 85 0.6× 71 1.0× 14 616

Countries citing papers authored by Mingdong Lu

Since Specialization
Citations

This map shows the geographic impact of Mingdong Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mingdong Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mingdong Lu more than expected).

Fields of papers citing papers by Mingdong Lu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mingdong Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mingdong Lu. The network helps show where Mingdong Lu may publish in the future.

Co-authorship network of co-authors of Mingdong Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Mingdong Lu. A scholar is included among the top collaborators of Mingdong Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mingdong Lu. Mingdong Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Yuanzheng, Jie Fu, Jinsong Ding, et al.. (2025). Hemin-Loaded Nanoparticles Improve Iron Supplementation and Gut Microbiota Balance in Iron-Deficiency Anemia Therapy. ACS Applied Materials & Interfaces. 17(46). 63198–63212.
2.
Feng, Shiyu, Haoke Zhang, Xiuting Chen, et al.. (2025). Human cytomegalovirus tegument protein UL23 promotes gastric cancer immune evasion by facilitating PD-L1 transcription. Molecular Medicine. 31(1). 57–57. 3 indexed citations
4.
Zhou, Yaping, Dan Tan, Guangyao Li, et al.. (2025). Antibody screening for tumor and immune hotspot targets: The frontier of new methods and technologies. Journal of Pharmaceutical Analysis. 16(2). 101417–101417.
5.
Hu, Yuanbo, Chenbin Chen, Kezhi Lin, et al.. (2025). NSUN2 promotes colorectal cancer progression and increases lapatinib sensitivity by enhancing CUL4B/ErbB‐STAT3 signalling in a non‐m5C manner. Clinical and Translational Medicine. 15(4). e70282–e70282. 2 indexed citations
6.
Hu, Xiaoqu, et al.. (2024). A Bioinspired Immunostimulatory System for Inducing Powerful Antitumor Immune Function by Directly Causing Plasma Membrane Rupture. Advanced Science. 11(20). e2305934–e2305934. 5 indexed citations
7.
Chen, Chenbin, Weiteng Zhang, Jie Lin, et al.. (2024). Development and validation of a machine learning-based 18F-fluorodeoxyglucose PET/CT radiomics signature for predicting gastric cancer survival. Cancer Imaging. 24(1). 99–99. 5 indexed citations
8.
Liu, Yiqing, et al.. (2024). Development and application of an RNA nanostructure to induce transient RNAi in difficult transgenic plants. Biotechnology Journal. 19(5). e2400024–e2400024. 3 indexed citations
9.
Mao, Chenchen, Dong Xing, Teming Zhang, et al.. (2024). Resting natural killer cells promote the progress of colon cancer liver metastasis by elevating tumor-derived stem cell factor. eLife. 13. 1 indexed citations
10.
Pan, Qunxiong, et al.. (2023). Intermediate endpoints as surrogates for outcomes in cancer immunotherapy: a systematic review and meta-analysis of phase 3 trials. EClinicalMedicine. 63. 102156–102156. 7 indexed citations
11.
Hu, Yuanbo, Chenbin Chen, Xinya Tong, et al.. (2021). NSUN2 modified by SUMO-2/3 promotes gastric cancer progression and regulates mRNA m5C methylation. Cell Death and Disease. 12(9). 842–842. 154 indexed citations
12.
Lu, Mingdong, et al.. (2021). Pan-cancer analysis of SETD2 mutation and its association with the efficacy of immunotherapy. npj Precision Oncology. 5(1). 51–51. 62 indexed citations
14.
Li, Pihong, Jianda Dong, Xiang Zhou, et al.. (2017). Expression patterns of microRNA-329 and its clinical performance in diagnosis and prognosis of breast cancer. OncoTargets and Therapy. Volume 10. 5711–5718. 17 indexed citations
15.
Sun, Weijian, Hao Wu, Mingdong Lu, et al.. (2016). Expression of AQP1 Was Associated with Apoptosis and Survival of Patients in Gastric Adenocarcinoma. Digestive Surgery. 33(3). 190–196. 9 indexed citations
16.
Sun, Weijian, He Huang, Bin He, et al.. (2016). Romidepsin induces G2/M phase arrest via Erk/cdc25C/cdc2/cyclinB pathway and apoptosis induction through JNK/c-Jun/caspase3 pathway in hepatocellular carcinoma cells. Biochemical Pharmacology. 127. 90–100. 71 indexed citations
17.
Lu, Mingdong, Qing Kong, Xiaowei Xu, et al.. (2015). Evaluation of Apoptotic and Growth Inhibitory Activity of Phloretin in BGC823 Gastric Cancer Cell. Tropical Journal of Pharmaceutical Research. 14(1). 27–27. 10 indexed citations
18.
Li, Liyi, et al.. (2015). Cruciferous vegetable consumption and the risk of pancreatic cancer: a meta-analysis. World Journal of Surgical Oncology. 13(1). 44–44. 38 indexed citations
19.
Zhou, Xiang, Weijian Sun, Wei‐Ming Wang, et al.. (2013). Artesunate inhibits the growth of gastric cancer cells through the mechanism of promoting oncosis both in vitro and in vivo. Anti-Cancer Drugs. 24(9). 920–927. 52 indexed citations
20.
Zheng, Zhiqiang, Mingdong Lu, Weijian Sun, et al.. (2011). Double contrast–enhanced ultrasonography for the preoperative evaluation of gastric cancer: A comparison to endoscopic ultrasonography with respect to histopathology. The American Journal of Surgery. 202(5). 605–611. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026